This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,659 Years Active: 2012
Title: The Innovations of Ho CHul Yoon
Introduction
Ho CHul Yoon is a notable inventor based in Suwon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of human interferon-beta muteins. His work has implications for therapeutic applications, showcasing the potential of modified proteins in medical treatments.
Latest Patents
Ho CHul Yoon holds 1 patent for his invention titled "Human interferon-beta mutein." This invention specifically relates to a human interferon-beta mutein that possesses one or two additional sugar chains compared to natural human interferon-beta. This modification may enhance the efficacy and stability of the interferon, making it a valuable asset in therapeutic contexts.
Career Highlights
Throughout his career, Ho CHul Yoon has focused on innovations that bridge the gap between basic research and practical applications in medicine. His dedication to advancing biotechnological solutions has positioned him as a key figure in his field.
Collaborations
Ho CHul Yoon has worked alongside talented colleagues, including Moon Kyoung So and Ji Tai Kim. Their collaborative efforts contribute to the ongoing research and development in biotechnology, fostering an environment of innovation and discovery.
Conclusion
Ho CHul Yoon's contributions to the field of biotechnology, particularly through his patent on human interferon-beta muteins, highlight the importance of innovation in medical science. His work exemplifies the potential for modified proteins to improve therapeutic outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile